The incidence of thyroid cancer is affected by the characteristics of a healthcare system

Journal of Korean Medical Science

Volumn 27, Issue 12, 2012, Pages 1491-1498

  Lee, Tae Jin ^a   Kim, Sun ^a   Cho, Hong Jun ^b   Lee, Jae Ho ^c  

^a Seoul National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Healthcare system; Overdiagnosis; Public health expenditure; Thyroid neoplasms

Indexed keywords

ARTICLE; DEVELOPED COUNTRY; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; MORTALITY; OVERDIAGNOSIS; PUBLIC HEALTH EXPENDITURE; REGRESSION ANALYSIS; THYROID TUMOR;

HEALTHCARE SYSTEM; OVERDIAGNOSIS; PUBLIC HEALTH EXPENDITURE; THYROID NEOPLASMS;

DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; HUMANS; INCIDENCE; REGRESSION ANALYSIS; THYROID NEOPLASMS;

EID: 84872588472     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.12.1491     Document Type: Article

References (39)

1. Zheng TZ, Holford TR, Chen YT, Ma JZ, Flannery J, Liu W, Russi M, Boyle P. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 1996; 67: 504-9.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011 [accessed on 5 August 2012].
3. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Ahang Y, Bai Y, Zhu C, Guo GL, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20: 525-31.
4. Truong T, Rougier Y, Dubourdieu D, Guihenneuc-Jouyaux C, Orsi L, Hémon D, Guénel P. Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). Eur J Cancer Prev 2007; 16: 62-70.
5. National Cancer Information Center of Korea. Statistics about thyroid cacner. Available at http://www.cancer.go.kr/ncic/index.html [accessed on 7 August 2011].
6. Weiss W. Changing incidence of thyroid cancer. J Natl Cancer Inst 1979; 62: 1137-42.
7. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992; 359: 21.
8. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259-77.
9. Golding SJ, Shrimpton PC. Radiation dose in CT: are we meeting the challenge? Br J Radiol 2002; 75: 1-4.
10. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiationinduced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176: 289-96.
11. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7.
12. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 2007; 177: 1357-61.
13. Lloyd R, De Lellis R, Heitz P, Eng C. World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs. Lyon, France: IARC Press, 2004.
14. Ghori FY, Gutterman-Litofsky DR, Jamal A, Yeung SC, Arem R, Sherman SI. Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid 2002; 12: 1009-16.
15. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 2008; 19: 585-93.
16. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981-90.
17. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13.
18. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531-8.
19. Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970-1998. Health Serv Res 2003; 38: 831-65
20. Elola J, Daponte A, Navarro V. Health indicators and the organization of health care systems in western Europe. Am J Public Health 1995; 85: 1397-401.
21. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 1973; 51: 95-124.
22. Quaglia A, Vercelli M, Lillini R, Mugno E, Coebergh JW, Quinn M, Martinez-Garcia C, Capocaccia R, Micheli A; ELDCARE Working Group. Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project). Crit Rev Oncol Hematol 2005; 54: 117-28.
23. Nixon J, Ulmann P. The relationship between health care expenditure and health outcomes. Eur J Health Econ 2006; 7: 7-18.
24. Asiskovitch S. Gender and health outcomes: the impact of healthcare systems and their financing on life expectancies of women and men. Soc Sci Med 2010; 70: 886-95.
25. Babazono A, Hillman AL. A comparison of international health outcomes and health care spending. Int J Technol Assess Health Care 1994;10: 376-81.
26. Enthoven AC. The history and principles of managed competition. Health Aff (Millwood) 1993; 12: 24-48.
27. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 v2.0. in cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press, 2004.
28. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2. in cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press, 2010.
29. Organization for Economic Co-operation and Development. OECD Health Data 2010 - Frequently Requested Data (online database: /, based on Oct 2010 ver). Paris: OECD, 2010.
30. Paris V, Devaux M, Wei L. Health systems institutional characteristics: a survey of 29 OECD countries. Paris: OECD, 2010.
31. Wagstaff A. Social health insurance vs. tax-financed health systems: evidence from the OECD. Wasington, DC: World Bank, 2009.
32. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115: 3801-7.
33. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010; 200: 454-61.
34. Baker SR, Bhatti WA. The thyroid cancer epidemic: is it the dark side of the CT revolution? Eur J Radiol 2006; 60: 67-9.
35. Franks P, Clancy CM, Nutting PA. Gatekeeping revisited: protecting patients from overtreatment. N Engl J Med 1992; 327: 424-9.
36. Grant WB. A multicountry ecological study of risk-modifying factors for prostate cancer: apolipoprotein E epsilon4 as a risk factor and cereals as a risk reduction factor. Anticancer Res 2010; 30: 189-99.
37. Chen DT, Chou YF, Wu HP, Hsu LP, Wen IS, Lee CF, Chen PR. Income and the incidence of oral cavity cancer: cross-national study. J Otolaryngol Head Neck Surg 2009; 38: 208-11.
38. Or Z. Exploring the effects of health care on mortality across OECD countries. Paris: OECD, 2001.
39. Or Z, Wang J, Jamison D. International differences in the impact of doctors on health: a multilevel analysis of OECD countries. J Health Econ 2005; 24: 531-60.